Medical News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Cells, Immunology, T-Cell, Tubercolosis, Canada, University of Mon, McGill University , Vaccines, Infectious Desease, BCG, Stem Cells, Bone Marrow Cell Therapy, Immune Response, Innate Immune Response, Macrophages

Re-Programming Innate Immune Cells to Fight Tuberculosis

Canadian researchers’ innovative work promises to make vaccines more effective against tuberculosis and other infectious diseases like the flu.

Medicine

Science

Channels:

Breast Cancer, Diet, Estrogen, drugs, , Chemotherapy, Therapeutics

Estrogen-Mimicking Compounds in Foods May Reduce Effectiveness of Breast Cancer Treatment

Scientists from The Scripps Research Institute have discovered that two estrogen-mimicking compounds found in many foods appear to potently reverse the effects of palbociclib/letrozole, a popular drug combination for treating breast cancer.

Medicine

Business

Channels:

calidad, Mayo Clinic

Mayo Clinic Recibe Altas Calificaciones Por Su Calidad Hospitalaria

Los Centros para Servicios de Medicare y Medicaid en Estados Unidos otorgaron calificaciones con estrellas a 14 hospitales de Mayo Clinic en Arizona, Florida, Rochester y el Sistema de Salud de Mayo Clinic por su calidad general.

Medicine

Channels:

Antimicrobial Agents and Chemotherapy, Antimicrobial Agents, Case Western Reserve University School Of Medicine, University Hospitals Cleveland Medical Center, mahmoud ghannoum, Candida auris, c. auris, Yeast, antifungals, Superbugs, microscopic yeast, Mouse Model, Infections, amplyx pharmaceuticals, Pharmaceuticals, scynexis incorporated, cidara therapeutics

New Antifungal Provides Hope in Fight Against Superbugs

Microscopic yeast have been wreaking havoc in hospitals around the world—creeping into catheters, ventilator tubes, and IV lines—and causing deadly invasive infection. One culprit species, Candida auris, is resistant to many antifungals, meaning once a person is infected, there are limited treatment options. But in a recent Antimicrobial Agents and Chemotherapy study, researchers confirmed a new drug compound kills drug-resistant C. auris, both in the laboratory and in a mouse model that mimics human infection.

Medicine

Channels:

Medicaid

States May Set #Medicaid Work Requirements for 1st Time; Leader of Related Study Available to Comment

renutipirneni.jpg

Medicine

Channels:

Prostate Cancer, Cancer, Urology, Genetics, Precision Medicine, polygenic hazard score, GWAS

New Polygenic Hazard Score Predicts When Men Develop Prostate Cancer

An international team, led by researchers at the University of California San Diego School of Medicine, has developed and validated a genetic tool for predicting age of onset of aggressive prostate cancer, a disease that kills more than 26,000 American men annually.

Medicine

Channels:

Bowel Cancer, Colorectal Cancer, Cancer, Research, cancer patie

Researcher from Queen’s University Publishes Groundbreaking Plan to End Bowel Cancer

Bowelcancer.jpg

A groundbreaking report, led by Professor Mark Lawler, Chair in Translational Cancer Genomics at Queen’s University Belfast highlights a plan to end bowel cancer, the second most common cause of cancer death in Europe. The report has been published in the January edition of top international journal Gut (http://gut.bmj.com/).

Medicine

Channels:

Keck Medicine of USC, Norris Healthcare Center, USC, University Of Southern California, USC Health Sciences Campus, new building, Women's Health Care, infusion clinic, Outpatient Surgery Center, Urology, Urologic Cancer, Ambulatory Care, Los Angeles

New Norris Healthcare Center Opens on USC’s Health Sciences Campus

_ZS_1016.JPG

Keck Medicine of USC is significantly expanding its patient care services and health care facilities with the opening of the new Norris Healthcare Center, a seven-story, state-of-the-art facility providing multidisciplinary ambulatory care.

Medicine

Science

Channels:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Jan-2018 12:00 PM EST

Medicine

Science

Channels:

Drug Discovery, Drug Development, High-throughput screening, CD73 inhibitors, multiplex RF-MSMS Assay, immuno-oncology, laboratory automation

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 17-Jan-2018 2:00 AM EST







Chat now!